Refeyn appoints new Chief Marketing Officer
Refeyn is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024. Forming part of Refeyn’s executive team, Fiona will bring with her a wealth of experience from over 25 years in the biotechnology sector.
Refeyn strengthens capability with new US Headquarters in Boston area
New US customer interaction center opens in Massachusetts’ Waltham Biotech Hub with 3rd annual Mass Photometry Summit set to highlight latest advances
Expert interview on accelerating AAV development processes
ABL, an Institut Mérieux Company, is a distinguished contract development and manufacturing organization (CDMO) providing GMP viral vectors from early stage to market.
Refeyn’s new KaritroMP quickly analyzes large viral vectors
New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors within just minutes
MassFerence P2 calibrator for AAV analytics with mass photometry
Refeyn is pleased to announce the expansion of the consumables portfolio for mass photometry. Refeyn has created a new product line of mass reference standards, MassFerence, which help streamline sample characterization with mass photometry.
A fresh look at protein aggregation using mass photometry
Neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, both involve an accumulation of protein aggregates [1],[2]. Monitoring and studying small oligomers, which are present in the early stages of disease, can be challenging, due to their transient and heterogeneous nature [1].
Analyze low-affinity interactions with MassFluidix® HC
New microfluidic system enhances protein analysis workflows for the study of weak protein-protein interactions by mass photometry
Refeyn announces appointment of a new CEO
Refeyn, a leading Life Science instrumentation company pioneering mass photometry, announced today that Gerry Mackay has been appointed the new CEO of the company effective January 1st, 2024.
Studying protein oligomerization with mass photometry
Lipoprotein lipase (LPL) has long been a focal point in the study of lipid metabolism. Its role in releasing free fatty acids from triglycerides, allowing their transport across cell membranes, is vital for energy production, while dysregulation of this enzyme has been linked to cardiovascular disease [1].
Overcome analytical bottlenecks with mass photometry
Dr. Martin E. and Dr. Marie A. are experienced scientists – characterizing antibody and gene therapy samples at one of the top 5 pharmaceutical companies. Their lab recently acquired a TwoMP Auto mass photometer and they spoke to us about their initial experience with the instrument and how they are using mass photometry to overcome their analytical challenges.
